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In a cohort study, ovarian cancer (280 cases) showed no significant association with tea or coffee, the multivariable rate ratios being
0.94 (95% confidence interval (CI): 0.89, 1.00) and 1.04 (95% CI: 0.97, 1.12) per cup per day, respectively. A meta-analysis also
produced no significant findings overall, though the cohort studies showed a significant inverse association for tea.
British Journal of Cancer (2007) 97, 1291–1294. doi:10.1038/sj.bjc.6604008 www.bjcancer.com
Published online 9 October 2007
& 2007 Cancer Research UK
Keywords: tea; coffee; ovarian neoplasms; meta-analysis; aetiology; cohort studies
                            
Tea and coffee are widely consumed around the world and
may affect human health. Several case-control and cohort
studies have analysed the relationship with ovarian cancer
risk, yielding inconclusive results. We analysed the associa-
tion between tea, coffee and ovarian cancer in a prospective
cohort study and summarised results of previous studies in a
meta-analysis.
MATERIALS AND METHODS
The cohort
The Netherlands Cohort Study on Diet and Cancer is a prospective
cohort study (n¼120852) that started in September 1986 with the
enrolment of participants aged 55–69, among whom 62573 were
women (van den Brandt et al, 1990). Data processing and analysis
Table 1 Rate ratios of ovarian cancer according to coffee and tea consumption
a
Age-adjusted Multivariable adjusted
b
Mean (cups
per day) Cases (n)
Person- years
in subcohort RR 95% CI RR 95% CI
Coffee (cups per day)
0–o1 0.5 15 1913 0.70 0.39, 1.25 0.73 0.41, 1.31
1–o3 2.5 87 7647 1.00 Reference 1.00 Reference
3–o5 4.3 119 11,243 0.96 0.71, 1.29 1.00 0.74, 1.35
X5 6.9 59 5124 1.07 0.75, 1.53 1.08 0.75, 1.57
P-trend¼0.33 P-trend¼0.35
Coffee increment (1
cup per day)
1.04 0.98, 1.11 1.04 0.97, 1.12
Tea (cups per day)
0–o1 0.5 66 5455 1.13 0.81, 1.57 1.10 0.78, 1.54
1–o3 2.4 107 9856 1.00 Reference 1.00 Reference
3–o5 4.2 83 7262 1.03 0.76, 1.40 1.04 0.76, 1.42
X5 6.8 24 3354 0.64 0.40, 1.02 0.65 0.41, 1.03
P-trend¼0.07 P-trend¼0.12
Tea increment (1 cup
per day)
0.94 0.88, 1.00 0.94 0.89, 1.00
Abbreviations: RR¼rate ratio; CI¼confidence interval.
aThe Netherlands Cohort Study (1986–1999).
bAdjusted for age (years), use of oral contraceptives (ever/never), parity
(number of children), cigarette smoking (current, ex-smoker, never smoker). Coffee and tea were mutually adjusted.
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women was randomly drawn from the cohort at baseline. After
exclusion of prevalent cancer cases (other than skin cancer)
(n¼151), women who reported at baseline to have undergone an
oophorectomy (n¼32) and subcohort members with incomplete
or inconsistent dietary questionnaire data (n¼190) (Goldbohm
et al, 1994), incomplete information on tea or coffee consumption
(n¼80) or confounders (n¼53), 2083 subcohort members were
available for analysis.
Follow-up
The subcohort has been followed up for emigration and vital
status. No female subcohort members were lost to follow-up.
NOTE: Weights are from random effects analysis
Heterogeneity between groups: P = 0.009
Overall  (I-squared = 63.3%, P = 0.002)
Larsson (2005)
Kuper (2000)
Gates (2007)
Subtotal (I-squared = 21.9%, P = 0.275)
Tavani (2001)
Baker (2007)
Steevens (2007)
La Vecchia (1992)
Zheng (1996)
Zhang (2002)
Silvera (2007)
Subtotal (I-squared = 66.5%, P = 0.006)
Study ID
Case–control
Case–control
Cohort
Jordan (2004)
Miller (1987)
0.85 (0.71, 1.01)
0.54 (0.32, 0.93)
1.06 (0.83, 1.36)
0.63 (0.40, 0.99)
0.71 (0.55, 0.93)
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NOTE: Weights are from random effects analysis
Heterogeneity between groups: P= 0.191
Overall (I-squared = 50.5%, P = 0.013)
Miller (1987)
La Vecchia (1984)
Steevens (2007)
Tavani (2001)
Cohort
Larsson (2005)
Snowdon (1984)
Kuper (2000)
Subtotal  (I-squared = 0.0%, P = 0.703)
Whittemore (1988)
Baker (2007)
Polychronopoulou (1993)
Subtotal (I-squared = 60.2%, P = 0.005)
Riman (2004)
Hartge (1982)
Hirose (2007)
Study ID
Silvera (2007)
Jordan (2004)
1.18 (0.97, 1.44)
1.10 (0.60, 2.01)
2.20 (1.22, 3.97)
1.48 (0.80, 2.75)
0.93 (0.69, 1.26)
1.07 (0.64, 1.79)
1.20 (0.59, 2.45)
1.88 (1.14, 3.10)
1.32 (0.99, 1.77)
2.07 (0.97, 4.40)
1.05 (0.73, 1.52)
1.09 (0.52, 2.28)
1.15 (0.89, 1.47)
0.68 (0.42, 1.10)
1.40 (0.63, 3.13)
1.33 (0.68, 2.60)
1.62 (0.95, 2.76)
0.62 (0.41, 0.94)
100.00
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Figure 1 Meta-analysis of case-control and cohort studies investigating tea and coffee consumption (highest vs lowest) in relation to ovarian cancer risk.
Note: In this meta-analysis, we used the lowest category as a reference in all studies, for reasons of comparability.
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by record linkage to the Netherlands Cancer Registry. During 13.3
years of follow-up, 362 incident, microscopically confirmed
ovarian carcinomas (ICD-O-3 code C56.9) were identified. After
exclusion of borderline invasive (n¼14) and non-epithelial
tumours (n¼12) and women with incomplete or inconsistent
dietary questionnaire data (n¼36), missing information on tea or
coffee consumption (n¼11) or confounders (n¼9), 280 cases
remained available for analyses.
Questionnaire
A self-administered questionnaire on risk factors for cancer,
including a food frequency questionnaire (FFQ), was completed by
all cohort members at baseline. The respondents were asked
whether they drank tea or coffee and, if so, how many cups per
day. The type of tea was not specified but this population rarely
drank any tea other than black tea in 1986 (Goldbohm et al, 1996).
We validated the FFQ against a 9-day diet record (Goldbohm et al,
1994) and established the 5-year reproducibility of the FFQ
(Goldbohm et al, 1995).
Data analysis
Person-years of follow-up were calculated for the subcohort
members from the start of the study until the date of ovarian
cancer diagnosis, death, emigration or end of follow-up. Incidence
rate ratios (RR) and corresponding 95% confidence intervals (CI)
were estimated in age-adjusted and multivariable-adjusted ana-
lyses using Cox proportional hazards model with Stata 9.0.
Meta-analysis
We performed a meta-analysis of case-control and cohort studies
on tea, coffee and ovarian cancer using the Stata procedure
‘metan’. A random effects model was used because of significant
heterogeneity. On tea drinking and ovarian cancer, eight case-
control studies (Byers et al, 1983; Miller et al, 1987; La Vecchia
et al, 1992; Kuper et al, 2000; Tavani et al, 2001; Zhang et al,
2002; Jordan et al, 2004; Baker et al, 2007) and, including this
study, five cohort studies (Zheng et al, 1996; Larsson and Wolk,
2005b; Gates et al, 2007; Silvera et al, 2007) have been conducted.
Coffee drinking and ovarian cancer risk was investigated in 16
case-control studies (Trichopoulos et al, 1981; Hartge et al, 1982;
Byers et al, 1983; Cramer et al, 1984; La Vecchia et al, 1984; Tzonou
et al, 1984; Miller et al, 1987; Whittemore et al, 1988;
Polychronopoulou et al, 1993; Kuper et al, 2000; Tavani et al,
2001; Jordan et al, 2004; Riman et al, 2004; Baker et al, 2007) and,
including this study, five cohort studies (Snowdon and Phillips,
1984; Stensvold and Jacobsen, 1994; Larsson and Wolk, 2005a;
Silvera et al, 2007). We had to exclude from the meta-analysis
studies that did not report 95% CIs (Trichopoulos et al, 1981;
Byers et al, 1983; Cramer et al, 1984; Tzonou et al, 1984; Stensvold
and Jacobsen, 1994).
RESULTS
After 13.3 years of follow-up, there were 280 epithelial ovarian
carcinomas, 47.1% of which were serous carcinomas, 10.0%
mucinous carcinomas, 9.3% endometrioid carcinomas and 4.3%
clear cell carcinomas. Tea was drunk by 489% of the subjects,
coffee by 496% and only 0.2% drank neither. Mean daily tea
consumption (s.d.) was 3.1 (2.1) cups for subcohort members and
2.9 (1.8) cups for cases. Older women, never smokers, more highly
educated respondents and women with a normal body mass index
(BMI) drank more tea. Mean daily coffee consumption (s.d.) was
4.0 (2.0) cups for subcohort members and 4.1 (2.0) cups for cases.
A lower age, current smoking, a lower level of education and a
higher BMI were associated with higher coffee consumption.
Table 1 shows RRs for ovarian cancer for tea and coffee
consumption. Tea consumption was inversely associated with
ovarian cancer risk, although not statistically significant and coffee
consumption showed no association. The proportional hazards
assumption was not violated and there was no effect modification.
The category 1–o3 cups per day was chosen as a reference
because there were too few subjects in the lowest category.
We excluded subjects with o2 years of follow-up to check for
protopathic bias, analysed stable coffee drinkers separately and
corrected for acrylamide in coffee, but none of these analyses
affected the results. Subtype analyses showed that tea was inversely
associated with serous tumours, whereas it was related to increased
risk of mucinous and endometrioid tumours, giving some
indication for heterogeneity.
In the meta-analysis (Figure 1), tea was found to be inversely
associated with ovarian cancer when study results were pooled.
The association was strongest, and statistically significant, in
cohort studies. Coffee consumption was related to increased
ovarian cancer risk when study results were pooled. A stronger,
borderline significant association was seen in cohort studies.
DISCUSSION
In this cohort study, coffee consumption was not associated with
the risk of epithelial ovarian cancer in postmenopausal women.
Tea drinking was inversely, but not statistically significantly,
associated with ovarian cancer risk. An important strength of this
study is the prospective character, which makes recall bias
unlikely.
The heterogeneity between the outcomes observed in different
studies may be attributable to effect modification by genetic
factors, for example polymorphisms of the CYP1A2 genotype, an
enzyme involved in the metabolism of caffeine (Goodman et al,
2003). As tea and coffee are very common beverages, even a
modest decrease or increase of ovarian cancer risk found in the
meta-analysis is of importance.
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